+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
From
Parkinson's Disease: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Parkinson's Disease: 68-Market Analysis and Sales Forecast

  • Report
  • August 2025
  • 20 Pages
  • Global
From
From
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2025

  • Clinical Trials
  • July 2025
  • 195 Pages
  • Global
From
From
Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • July 2025
  • 543 Pages
  • Global
From
Dementia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Dementia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • July 2025
  • 989 Pages
  • Global
From
From
From
From
From
From
Multiple Sclerosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Multiple Sclerosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • June 2025
  • Global
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more